{"id":36810,"date":"2025-11-25T14:11:19","date_gmt":"2025-11-25T20:11:19","guid":{"rendered":"https:\/\/youscript.com\/?p=36810"},"modified":"2026-06-17T15:32:52","modified_gmt":"2026-06-17T20:32:52","slug":"pgxperts-bytes-the-case-for-dpyd-testing","status":"publish","type":"post","link":"https:\/\/youscript.com\/pgxperts-bytes-the-case-for-dpyd-testing\/","title":{"rendered":"PGxperts\u2122 Bytes: The Case for DPYD Testing"},"content":{"rendered":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” flex_gap_desktop=”10px” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text css=”” text_direction=”default”]\"\"<\/a><\/p>\n

YouScript<\/a> is excited to announce the next PGxperts\u2122<\/sup> Bytes – a series of short discussions covering important topics across the pharmacogenomics space.<\/p>\n

Host Joel Diamond, CMO of Aranscia<\/a>\u00ae<\/sup>, and Houda Hachad<\/a>, Vice President of Clinical Operations at Aranscia<\/a>, discuss the case for DPYD<\/em> testing.[\/vc_column_text][nectar_video_lightbox link_style=”play_button_with_text” nectar_play_button_color=”Default-Accent-Color” nectar_play_button_style=”default” font_style=”h3″ video_url=”https:\/\/player.vimeo.com\/video\/1139099444?h=9cad266f41&badge=0&autopause=0&player_id=0&app_id=58479″ link_text=”Watch the episode here!”][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” flex_gap_desktop=”10px” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default”…<\/p>\n","protected":false},"author":20,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[13],"tags":[293,700,157],"class_list":["post-36810","post","type-post","status-publish","format-standard","category-news","tag-pgx","tag-pgxperts-bytes","tag-pharmacogenomics"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t